A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This trial is a Phase 1a/1b, randomized, double-blind, placebo-controlled study designed to
assess the safety, tolerability, and pharmacokinetics of single and multiple ascending oral
doses of prosetin administered to healthy adult subjects.